Cost-effectiveness analysis of olaparib maintenance therapy for BRCA mutation ovarian cancer in the public sector in Malaysia.

by Chee Meng Yong, Prathepamalar A P Yehgambaram, Shaun Wen Huey Lee
Published 2024-01-01